ImpriMed will be exhibiting at TRI-CON to present our integrated precision medicine approach for oncology research and drug development. Meet our team to learn how our ex vivo testing platform and AI models enable smarter enrollement strategies, and support trial enrichment and precision-driven design.
Click here to go to the official event page →ImpriMed will be exhibiting at TRI-CON to present our integrated precision medicine approach for oncology research and drug development. Meet our team to learn how our ex vivo testing platform and AI models enable smarter enrollement strategies, and support trial enrichment and precision-driven design.
